Based on the above summary and analysis, ginsenoside Rb1 exerts significant anti-obesity, anti-hyperglycemic, and anti-diabetic effects by regulating the effects of glycolipid metabolism and improving insulin and leptin sensitivities, as showed in Figure 2. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.